Invention Grant
- Patent Title: Antibody molecules to TIM-3 and uses thereof
-
Application No.: US15462585Application Date: 2017-03-17
-
Publication No.: US09884913B2Publication Date: 2018-02-06
- Inventor: Catherine Anne Sabatos-Peyton , Barbara Brannetti , Alan S. Harris , Thomas Huber , Thomas Pietzonka , Jennifer Marie Mataraza , Walter A. Blattler , Daniel J. Hicklin , Maximiliano Vasquez , Rosemarie H. DeKruyff , Dale T. Umetsu , Gordon James Freeman , Tiancen Hu , John A. Taraszka , Fangmin Xu
- Applicant: Novartis AG , DANA-FARBER CANCER INSTITUTE, INC. , Children's Medical Center Corporation
- Applicant Address: CH Basel US MA Boston US MA Boston
- Assignee: Novartis AG,DANA-FARBER CANCER INSITITUTE, INC.,Children's Medical Center Corporation
- Current Assignee: Novartis AG,DANA-FARBER CANCER INSITITUTE, INC.,Children's Medical Center Corporation
- Current Assignee Address: CH Basel US MA Boston US MA Boston
- Agency: Lando & Anastasi, LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; G01N33/68
Abstract:
Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
Public/Granted literature
- US20170190777A1 ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF Public/Granted day:2017-07-06
Information query
